# Interest of Measuring P2X4 Receptors on Blood Monocytes as a Diagnostic Marker in Amyotrophic Lateral Sclerosis: P2X4 as a Diagnostic Biomarker for ALS

> **NCT07091799** · NA · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 50 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis &Amp; Other Neuromuscular Disorders

## Interventions

- **DIAGNOSTIC_TEST:** P2X4 receptors in blood samples

## Key facts

- **NCT ID:** NCT07091799
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2027-01
- **Final completion:** 2027-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07091799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07091799, "Interest of Measuring P2X4 Receptors on Blood Monocytes as a Diagnostic Marker in Amyotrophic Lateral Sclerosis: P2X4 as a Diagnostic Biomarker for ALS". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07091799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*